SPARC reports net loss of Rs 1.47 crore in Q2 FY15

03 Nov 2014 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for the second quarter ended September 30, 2014.

The company has reported a net loss of Rs 1.47 crore for the quarter as compared to a net loss of Rs 7.65 crore for the same quarter in the previous year. Total income of the company has increased by 61.32% at Rs 46.59 crore for quarter under review as compared to Rs 28.88 crore for the quarter ended September 30, 2013.

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

206.35 15.95 (8.38%)
22-Nov-2024 14:01 View Price Chart
Peers
Company Name CMP
Syngene Internation. 866.50
Sagility India 27.98
AGS Transact Tech 80.46
Just Dial 1075.00
Krystal Integrated 645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.